Winona Tse, MD
img_Winona Tse
PROFESSOR | Neurology
Are you a patient?
Specialties
Neurology
Research Topics
Neurology, Neuromodulation, Parkinson's Disease
Current Research Topics
Our research team includes: Mindy Lopez, CCRC, ACRP-PM, Clinical Research Manager Joan Bratton, BA, Clinical Research Associate Christina Rosario, BA, Clinical Research Coordinator II • A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to its Individual Components in Subjects With Early Parkinson’s Disease and to a Calibration Arm of Pramipexole ER. • An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson’s Disease Complicated by Motor Fluctuations ("OFF" Episodes) • A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (ASPEN-1) • A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (ASPEN-OLS) • RESTORE: A clinical study of patients with symptomatic neuRogenic orthostatic hypotEnsion to assess Sustained effecTs Of dRoxidopa thErapy • A Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of SEP-363856 in Subjects with Parkinson’s Disease Psychosis • A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy • PL101-LID201 - A 14 week, double-blind, randomized three arm, parallel group study to assess the efficacy and safety of two doses of pridopidine versus placebo for the treatment of levodopa induced dyskinesias in Patients with Parkinson’s disease.

MD, State University of NY at Stony Brook School of Medicine

Internship, Internal Medicine, Mount Sinai Hospital

Residency, Neurology, Mount Sinai Hospital

Fellowship, Neuromuscular Medicine, Cornell University Medical College

Certifications

Am Board of Electrodiagnostic Medicine
American Board of Psychiatry and Neurology
Publications

Selected Publications

Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials. Andrea Quattrone, Nicolai Franzmeier, Hans Jürgen Huppertz, Martin Klietz, Sebastian N. Roemer, David Williams, Anne Louise Lafontaine, Connie Marras, Mandar Jog, Michael Panisset, Anthony Lang, Lesley Parker, Alistair J. Stewart, Jean Christophe Corvol, Jean Philippe Azulay, Philippe Couratier, Brit Mollenhauer, Stefan Lorenzl, Albert Ludolph, Reiner Benecke, Günter Höglinger, Axel Lipp, Heinz Reichmann, Dirk Woitalla, Dennis Chan, Adam Zermansky, David Burn, Andrew Lees, Adam Boxer, Bruce L. Miller, Iryna V. Lobach, Erik Roberson, Lawrence Honig, Edward Zamrini, Rajesh Pahwa, Yvette Bordelon, Erika Driver-Dunkley, Stephanie Lessig, Mark Lew, Kyle Womack, Brad Boeve, Joseph Ferrara, Argyle Hillis, Daniel Kaufer, Rajeev Kumar, Tao Xie, Steven Gunzler, Theresa Zesiewicz, Praveen Dayalu, Winona Tse. Movement Disorders

Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x). Tien Dam, Adam L. Boxer, Lawrence I. Golbe, Günter U. Höglinger, Huw R. Morris, Irene Litvan, Anthony E. Lang, Jean Christophe Corvol, Ikuko Aiba, Michael Grundman, Lili Yang, Beth Tidemann-Miller, Joseph Kupferman, Kristine Harper, Kubra Kamisoglu, Michael J. Wald, Danielle L. Graham, Liz Gedney, John O’Gorman, Samantha Budd Haeberlein, Ikuko Aiba, Angelo Antonini, Diana Apetauerova, Jean Philippe Azulay, Ernest Balaguer Martinez, Jee Bang, Paolo Barone, Matthew Barrett, Danny Bega, Daniela Berg, Koldo Berganzo Corrales, Yvette Bordelon, Adam L. Boxer, Moritz Brandt, Norbert Brueggemann, Giovanni Castelnovo, Roberto Ceravolo, Rosalind Chuang, Sun Ju Chung, Alistair Church, Jean Christophe Corvol, Paola Cudia, Marian Dale, Luc Defebvre, Sophie Drapier, Erika D. Driver-Dunckley, Georg Ebersbach, Karla M. Eggert, Aaron Ellenbogen, Winona Tse. Nature Medicine

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT<sub>1A</sub> Agonist, in Patients With Parkinson Disease Psychosis A Pilot Study. Stuart H. Isaacson, Mark Goldstein, Rajesh Pahwa, Carlos Singer, Kevin Klos, Michael Pucci, Yi Zhang, David Crandall, Kenneth S. Koblan, Bradford Navia, Ira Goodman, Perminder Bhatia, Robert Hauser, James Scott, David Kreitzman, Kevin Black, Burton Scott, Jeffrey Ratliff, Jennifer Hui, Brian Maddux, Christopher Goetz, Fernando Pagan, David Song, Winona Tse, Andres Deik, Stewart Factor, Joohi Jimenez-Shahed, Jason Aldred, Alberto Vasquez, Ramon Gil, Peter LeWitt, Henry Paul Moore. Neurology: Clinical Practice

View All Publications